Crabtree TSJ, Adamson K, Reid H, Barnes D, et al. Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab 2022;24:1398-1401.
PMID: 35322528